ECI Pharmaceuticalisation Index™
Measuring the advancement of cannabis companies towards pharmaceutical-grade operations. Eight pillars. Five maturity levels. The definitive standard for the European cannabis sector.
Early stage. Basic processes are informal and inconsistent.
Processes are developing but not yet consistent or fully implemented.
Core systems are established and managed. Consistent execution across key areas.
Robust systems and data demonstrate readiness for GMP compliance.
Pharmaceutical-grade operations with continuous improvement and excellence.
The Index scores pharmaceutical readiness across eight pillars. Each pillar is independently scored and weighted, producing a nuanced maturity profile that identifies exactly where to focus improvement effort.
Adjust the sliders to simulate a Pharmaceuticalisation Index™ score profile. This is an indicative tool — the full assessment uses 100 validated questions with expert review and industry benchmarking.
Rate each of the eight pillars from 0 (not implemented) to 100 (pharmaceutical grade). The overall score is a weighted average reflecting each dimension's contribution to pharmaceutical maturity.
From a free initial diagnostic to the full professional assessment — the right level of rigour for every stage of the pharmaceuticalisation journey.
High-level diagnostic across 10 quality dimensions. The fastest way to identify priority areas and get personalised course recommendations.
Comprehensive GMP readiness assessment with deeper scoring, sub-category analysis and a full written gap report with prioritised improvement roadmap.
The full SOMF-based professional assessment. 100 validated questions across eight pillars with expert review, industry benchmarking and strategic roadmap.
Begin with the free GMP Readiness Index™. Understand where your facility stands, what to focus on first, and which ECI certifications will close the gaps fastest.